- Home
- HDL vs SPRY Comparison
HDL vs SPRY Comparison
Compare HDL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HDL
- SPRY
- Stock Information
- Founded
- HDL 2016
- SPRY 2015
- Country
- HDL Singapore
- SPRY United States
- Employees
- HDL N/A
- SPRY N/A
- Industry
- HDL Restaurants
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- HDL Consumer Discretionary
- SPRY Health Care
- Exchange
- HDL Nasdaq
- SPRY Nasdaq
- Market Cap
- HDL 1.2B
- SPRY 1.6B
- IPO Year
- HDL 2024
- SPRY N/A
- Fundamental
- Price
- HDL $19.29
- SPRY $17.69
- Analyst Decision
- HDL
- SPRY Strong Buy
- Analyst Count
- HDL 0
- SPRY 4
- Target Price
- HDL N/A
- SPRY $28.75
- AVG Volume (30 Days)
- HDL 3.0K
- SPRY 1.6M
- Earning Date
- HDL 08-26-2025
- SPRY 08-05-2025
- Dividend Yield
- HDL N/A
- SPRY N/A
- EPS Growth
- HDL 110.82
- SPRY N/A
- EPS
- HDL 0.06
- SPRY N/A
- Revenue
- HDL $789,766,000.00
- SPRY $97,122,000.00
- Revenue This Year
- HDL $17.95
- SPRY N/A
- Revenue Next Year
- HDL $13.32
- SPRY $170.64
- P/E Ratio
- HDL $33.44
- SPRY N/A
- Revenue Growth
- HDL 10.91
- SPRY 971120.00
- 52 Week Low
- HDL $13.94
- SPRY $8.91
- 52 Week High
- HDL $30.00
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- HDL N/A
- SPRY 60.97
- Support Level
- HDL N/A
- SPRY $16.40
- Resistance Level
- HDL N/A
- SPRY $18.05
- Average True Range (ATR)
- HDL 0.00
- SPRY 1.06
- MACD
- HDL 0.00
- SPRY 0.03
- Stochastic Oscillator
- HDL 0.00
- SPRY 62.54
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.